A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance. Joshi SK, Sharzehi S, Pittsenbarger J, Bottomly D, et al. Am J Hematol 2021;96:E226-E229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Joshi SK, Sharzehi S, Pittsenbarger J, Bottomly D, et al. A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance. Am J Hematol 2021;96:E226-E229.
PMID: 33780043